Anti-inflammatory evaluation and acute toxicity of three food supplements that contain Moussonia deppeana

Publication date: Available online 21 January 2017
Source:Asian Pacific Journal of Tropical Medicine
Author(s): Gabriel Alfonso Gutiérrez-Rebolledo, Mariana Zuleima Pérez-González, Alejandro Zamilpa, María Adelina Jiménez-Arellanes
ObjectiveTo identify the anti-inflammatory activity through two murine models and in the median Lethal Dose (LD50) of three dietary supplements that contain Moussonia deppeana.MethodsThe anti-inflammatory activity of three dietary supplements (Cicatrisan/Gastricus^®, Gastinol^®, and Gastrovita^®) EtOH extracts was evaluated by TPA and by carrageenan murine models; also, median Lethal Dose (LD50) was determined. Verbascoside was quantified by High-Performance Liquid Chromatography. β-sitosterol, stigmasterol and the mixture of ursolic and oleanolic acids were identified in all supplements by TLC; however, none of these dietary supplements contain verbascoside.ResultsFor the TPA model, Cicatrisan/Gastricus^® generated a notable effect with 38.24% inhibition. While in the carrageenan model, it also exhibited noteworthy anti-inflammatory activity of ear edema with 66.39% of paw edema inhibition at 150 mg/kg, followed by Gastinol^® and Gastrovita^® with ≈50% at 300 mg/kg. Finally, LD50 was >2 g/kg for all supplements, when was administered intragastrically and Body Weight (BW) gain in mice was not altered after 14 days.ConclusionsOf the three food supplements containing M. deppeana, only the EtOH extract from Cicatrisan/Gastricus^® formulation (tablets) showed significant anti-inflammatory activity in both experimental models and the LD50 was > 2 g/kg.



from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2kdlUlV
via IFTTT